Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI-906) or Placebo in Chemotherapy-Naive Patients With Non–Small-Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations
Titel:
Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI-906) or Placebo in Chemotherapy-Naive Patients With Non–Small-Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations
Auteur:
Leighl, Natasha B. Rizvi, Naiyer A. de Lima Jr., Lopes Gilberto Arpornwirat, Wichit Rudin, Charles M. Chiappori, Alberto A. Ahn, Myung-Ju Chow, Laura Q.M. Bazhenova, Lyudmila Dechaphunkul, Arunee Sunpaweravong, Patrapim Eaton, Keith Chen, Jihong Medley, Sonja Poondru, Srinivasu Singh, Margaret Steinberg, Joyce Juergens, Rosalyn A. Gadgeel, Shirish M.